Back to Search
Start Over
The Association between Noninfectious Uveitis and Coronavirus Disease 2019 Outcomes: An Analysis of United States Claims-Based Data
- Source :
- Ophthalmology, vol 129, iss 3
- Publication Year :
- 2022
- Publisher :
- eScholarship, University of California, 2022.
-
Abstract
- PurposeTo identify if noninfectious uveitis (NIU) is associated with a greater risk of Coronavirus Disease 2019 (COVID-19) infection, hospitalization, and death.DesignA retrospective cohort study from January 20, 2020 to December 31, 2020, using a national claims-based database.ParticipantsEnrollees who had continuous enrollment with both medical and pharmacy coverage for 3 years before January 20, 2020. Patients with an NIU diagnosis within 3 years of the start of the study were included in the NIU cohort. Those with infectious uveitis codes or new NIU diagnoses during the risk period were excluded.MethodsCox proportional hazard models were used to identify unadjusted hazard ratios (HRs) and adjusted HRs for all covariates for each outcome measure. Adjusted models accounted for patient demographics, health status, and immunosuppressive medication use during the risk period.Main outcome measuresRates of COVID-19 infection, COVID-19-related hospitalization, and COVID-19-related in-hospital death identified with International Classification of Disease 10th revision codes.ResultsThis study included 5 806 227 patients, of whom 29 869 (0.5%) had a diagnosis of NIU. On unadjusted analysis, patients with NIU had a higher rate of COVID-19 infection (5.7% vs. 4.5%, P < 0.001), COVID-19-related hospitalization (1.2% vs. 0.6%, P < 0.001), and COVID-19-related death (0.3% vs. 0.1%, P < 0.001). However, in adjusted models, NIU was not associated with a greater risk of COVID-19 infection (HR, 1.05; 95% confidence interval [CI], 1.00-1.10; P= 0.04), hospitalization (HR, 0.98; 95% CI, 0.88-1.09; P= 0.67), or death (HR, 0.90, 95% CI, 0.72-1.13, P= 0.37). Use of systemic corticosteroids was significantly associated with a higher risk of COVID-19 infection, hospitalization, and death.ConclusionsPatients with NIU were significantly more likely to be infected with COVID-19 and experience severe disease outcomes. However, this association was due to the demographics, comorbidities, and medications of patients with NIU, rather than NIU alone. Patients using systemic corticosteroids were significantly more likely to be infected with COVID-19 and were at greater risk of hospitalization and in-hospital death. Additional investigation is necessary to identify the impact of corticosteroid exposure on COVID-19-related outcomes.
- Subjects :
- Adult
Male
Outcome Assessment
Clinical Sciences
Ophthalmology & Optometry
COVID-19 deaths
Uveitis
Databases
Insurance Claim Review
Risk Factors
Opthalmology and Optometry
80 and over
Humans
Corticosteroids
Hospital Mortality
COVID-19 hospitalizations
Glucocorticoids
Factual
Proportional Hazards Models
Retrospective Studies
Aged
SARS-CoV-2
Prevention
COVID-19
Middle Aged
United States
Noninfectious uveitis
Hospitalization
Health Care
Public Health and Health Services
Female
COVID-19 hospitaliza-tions
Immunosuppressive Agents
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Ophthalmology, vol 129, iss 3
- Accession number :
- edsair.od.......325..6c095e14ce75d047c35a88505d9785bf